Functional properties and modulation of extracellular epitope - tagged CaV2.1 voltage-gated calcium channels

Depolarisation-induced Ca2+ influx into electrically excitable cells is determined by the density of voltage-gated Ca2+ channels at the cell surface. Surface expression is modulated by physiological stimuli as well as by drugs and can be altered under pathological conditions. Extracellular epitope tagging of channel subunits allows to quantify their surface expression and to distinguish surface channels from those in intracellular compartments. Here we report the first systematic characterisation of extracellularly epitope tagged CaV2.1 channels. We identified a permissive region in the pore-loop of repeat IV within the CaV2.1 α1 subunit which allowed integration of several different tags (hemagluttinine [HA], double HA; 6-histidine tag [His], 9-His, bungarotoxin-binding site) without compromising α1 subunit protein expression (in transfected tsA-201 cells) and function (after expression in X. laevis oocytes). Immunofluorescent studies revealed that the double-HA tagged construct (1722-HAGHA) was targeted to presynaptic sites in transfected cultured hippocampal neurons as expected for CaV2.1 channels. We also demonstrate that introduction of tags into this permissive position creates artifical sites for channel modulation. This was demonstrated by partial inhibition of 1722-HA channel currents with anti-HA antibodies and the concentration-dependent stimulation or partial inhibition by Ni-nitrilo triacetic acid (NTA) and novel bulkier derivatives (Ni-trisNTA, Ni-tetrakisNTA, Ni-nitro-o-phenyl-bisNTA, Ni-nitro-p-phenyl-bisNTA). Therefore our data also provide evidence for the concept that artificial modulatory sites for small ligands can be introduced into voltage-gated Ca2+ channel for their selective modulation.

[1]  Valentina Trujillo Di Biase,et al.  Resolving sub-synaptic compartments with double immunofluorescence labeling in hippocampal neurons , 2009, Journal of Neuroscience Methods.

[2]  A. Koschak,et al.  Exploring the function and pharmacotherapeutic potential of voltage-gated Ca2+ channels with gene-knockout models , 2008 .

[3]  K. Watschinger,et al.  A Destructive Interaction Mechanism Accounts for Dominant-Negative Effects of Misfolded Mutants of Voltage-Gated Calcium Channels , 2008, The Journal of Neuroscience.

[4]  K. Watschinger,et al.  Pharmacological disruption of calcium channel trafficking by the α2δ ligand gabapentin , 2008, Proceedings of the National Academy of Sciences.

[5]  K. Watschinger,et al.  Time course and specificity of the pharmacological disruption of the trafficking of voltage-gated calcium channels by gabapentin , 2008, Channels.

[6]  R. Tampé,et al.  Controlling the activity of the 20S proteasome complex by synthetic gatekeepers. , 2006, Angewandte Chemie.

[7]  G. Obermair,et al.  Role of the synprint site in presynaptic targeting of the calcium channel CaV2.2 in hippocampal neurons , 2006, The European journal of neuroscience.

[8]  I. Bezprozvanny,et al.  CaV1.2 and CaV1.3 neuronal L‐type calcium channels: differential targeting and signaling to pCREB , 2006, The European journal of neuroscience.

[9]  J. Fallon,et al.  Dendrites Contain a Spacing Pattern , 2006, The Journal of Neuroscience.

[10]  W. Catterall,et al.  International Union of Pharmacology. XLVIII. Nomenclature and Structure-Function Relationships of Voltage-Gated Calcium Channels , 2005, Pharmacological Reviews.

[11]  M. Lei,et al.  Generation of functional ion-channel tools by E3 targeting , 2005, Nature Biotechnology.

[12]  S. Lata,et al.  High-affinity adaptors for switchable recognition of histidine-tagged proteins. , 2005, Journal of the American Chemical Society.

[13]  D. Surmeier,et al.  Association of CaV1.3 L-Type Calcium Channels with Shank , 2005, The Journal of Neuroscience.

[14]  P. Lory,et al.  Plasma Membrane Expression of T-type Calcium Channel α1 Subunits Is Modulated by High Voltage-activated Auxiliary Subunits* , 2004, Journal of Biological Chemistry.

[15]  G. Obermair,et al.  Differential targeting of the L‐type Ca2+ channel α1C (CaV1.2) to synaptic and extrasynaptic compartments in hippocampal neurons , 2004, The European journal of neuroscience.

[16]  G. Obermair,et al.  The small conductance Ca2+‐activated K+ channel SK3 is localized in nerve terminals of excitatory synapses of cultured mouse hippocampal neurons , 2003, The European journal of neuroscience.

[17]  John D. Scott,et al.  Trafficking of L-type Calcium Channels Mediated by the Postsynaptic Scaffolding Protein AKAP79* , 2002, The Journal of Biological Chemistry.

[18]  T. Hughes,et al.  A new way to rapidly create functional, fluorescent fusion proteins: random insertion of GFP with an in vitro transposition reaction , 2002, BMC Neuroscience.

[19]  A. Koschak,et al.  Functional Consequences of P/Q-type Ca2+Channel Cav2.1 Missense Mutations Associated with Episodic Ataxia Type 2 and Progressive Ataxia* , 2002, The Journal of Biological Chemistry.

[20]  D. Pietrobon,et al.  Calcium channels and channelopathies of the central nervous system , 2002, Molecular Neurobiology.

[21]  W. Reznikoff,et al.  Tn5/IS50 target recognition. , 1998, Proceedings of the National Academy of Sciences of the United States of America.

[22]  K. Beam,et al.  Tagging with green fluorescent protein reveals a distinct subcellular distribution of L-type and non-L-type Ca2+ channels expressed in dysgenic myotubes. , 1998, Proceedings of the National Academy of Sciences of the United States of America.

[23]  L. Birnbaumer,et al.  Cloning and expression of a third calcium channel beta subunit. , 1993, The Journal of biological chemistry.

[24]  K. Campbell,et al.  Sequence and expression of MRNAs encoding the α1 and α2 subunits of a DHP-sensitive calcium channel , 1988 .

[25]  Andrew Charles,et al.  The neurobiology of migraine. , 2010, Handbook of clinical neurology.

[26]  Aaron M. Beedle,et al.  ORL1 receptor–mediated internalization of N-type calcium channels , 2006, Nature Neuroscience.